儿童SARS-CoV-2相关炎症性多系统综合征(PIMS-TS)的腹部超声表现
回顾性分析140例疑似PIMS-TS患儿中120例确诊病例,102例初诊行腹部超声,84%异常,腹水最常见(64%),肠壁增厚14%、肠系膜炎症16%;随访38例,2个月后肠壁炎症均消失。
要点
- PIMS-TS患儿初诊腹部超声异常率84%,腹水为最常见征象(64%)。
- 肠壁增厚(14%)和肠系膜炎症(16%)均见于有腹部症状者,回肠末端最常受累。
- 随访超声显示肠壁炎症在2个月后消失(>2个月组0/17)。
核心结论
- 在102例初诊行腹部超声的PIMS-TS患儿中,14例(14%)有肠壁炎症、16例(16%)有肠系膜水肿,所有超声异常在2个月后消失。
研究设计与样本
- 回顾性研究,纳入2020年4月至2021年6月疑似PIMS-TS的儿童和年轻成人140例,其中120例确诊(中位年龄9岁,四分位距7-12岁,65例男性),102例初诊行腹部超声,38例行随访超声,采用描述性统计并计算观察者间变异。
关键影像表现/征象
- 腹水为最常见异常,见于65/102例(64%;95% CI:54,73)。
- 肠壁增厚见于14/102例(14%;95% CI:7,20),肠系膜炎症见于16/102例(16%;95% CI:9,23),均伴有腹部症状。
- 肠壁增厚者中,远端及末端回肠最常受累(8/14例,57%)。
诊断标准与关键数值
- 初诊腹部超声异常率84%(86/102)。
- 随访不足2个月者肠壁炎症降至3/27例(11%;95% CI:-1,23),随访超过2个月者降至0/17例(0%)。
- 6个月随访时腹部症状降至7/56例(13%)。
临床应用与阅片要点
- 初诊腹部超声可评估腹水、肠壁增厚及肠系膜炎症,肠壁增厚者需注意远端及末端回肠。
- 随访超声可用于观察肠壁炎症的动态变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Children with pediatric inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS), also known as multisystem inflammatory syndrome in children, present with abdominal pain among other nonspecific symptoms. Although initial imaging features of PIMS-TS have been reported, the duration of sonographic features remains unknown. Purpose To describe the abdominal US features of PIMS-TS at initial presentation and follow-up. Materials and Methods A retrospective review of children and young adults presenting with clinical features suspicious for PIMS-TS between April 2020 and June 2021 was carried out. US features were documented and reviewed at initial presentation and follow-up. Descriptive statistics were used and interobserver variability was calculated. Results Of 140 children and young adults presenting with suspected PIMS-TS, 120 had confirmed PIMS-TS (median age, 9 years; interquartile range, 7-12 years; 65 male patients) and 102 underwent abdominal US at presentation. PIMS-TS was present as a single abnormality in 109 of the 120 patients (91%) and abdominal symptoms were present in 104 of the 109 (95%). US examinations were abnormal in 86 of 102 patients (84%), with ascites being the most common abnormality in 65 (64%; 95% CI: 54, 73). Bowel wall thickening was present at US in 14 of the 102 patients (14%; 95% CI: 7, 20) and mesenteric inflammation was present in 16 (16%; 95% CI: 9, 23); all of these patients presented with abdominal symptoms. Among the patients with bowel wall thickening, the distal and terminal ileum were most involved (eight of 14 patients, 57%). Abdominal symptoms decreased to seven of 56 patients (13%) in those followed up at 6 months. Thirty-eight patients underwent follow-up US, and the presence of bowel inflammation had decreased to three of 27 patients (11%; 95% CI: -1, 23) in those followed up for less than 2 months and 0 of 17 (0%) in those followed up for more than 2 months. Conclusion Of 102 patients with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 who underwent US at presentation, 14 (14%) had abdominal US findings of bowel inflammation and 16 (16%) had mesenteric edema. All US abnormalities resolved after 2 months. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by van Rijn and Pajkrt in this issue.
引用
- Meshaka, Whittam, Guessoum, et al. Abdominal US in Pediatric Inflammatory Multisystem Syndrome Associated with SARS-CoV-2 (PIMS-TS). Radiology. 2021. PMID: 34874199. doi:10.1148/radiol.211737
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。